March 23, 2018Leukemia & lymphoma/Leukemia and lymphoma

Navigating the changing multiple myeloma treatment landscape: clinical practice patterns of MM patients treated in- and outside German DSMM study group trials

View Full Paper

Ask AI

Bookmark

Abstract

Over the last decade multiple myeloma (MM) diagnosis and therapy have greatly improved; notably, due to an increasing number of ‘novel agents’ (NA; e.g. proteasome inhibitors [PI], immunomodulatory...

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Gengenbach et al. (2018) studied this question.

synapsesocial.com/papers/6a9234f2af8726aa4b41d729 https://doi.org/10.1080/10428194.2018.1448084

View Full Paper

Ask AI

Bookmark

Navigating the changing multiple myeloma treatment landscape: clinical practice patterns of MM patients treated in- and outside German DSMM study group trials

Abstract

Discussion

Cite This Study

Navigating the changing multiple myeloma treatment landscape: clinical practice patterns of MM patients treated in- and outside German DSMM study group trials

Abstract

Discussion

Cite This Study

Also Consider

Also Consider